Renal Cancer - Results from #3100

Prognostic value of infiltrating immune cells in clear cell renal cell carcinoma (ccRCC). January 3, 2020

Three novel hub genes and their clinical significance in clear cell renal cell carcinoma. January 2, 2020

The covalent CDK7 inhibitor THZ1 enhances temsirolimus-induced cytotoxicity via autophagy suppression in human renal cell carcinoma. January 2, 2020

Predictors of Cytoreductive Nephrectomy for Metastatic Kidney Cancer in SEER and Metropolitan Detroit Databases. January 2, 2020

Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals. January 1, 2020

Cancer-Specific Loss of Urocortin 3 in Human Renal Cancer. January 1, 2020

Knockdown of long noncoding RNA DLEU1 suppresses the progression of renal cell carcinoma by downregulating the Akt pathway. January 1, 2020

Clinical features and outcomes in kidney transplant recipients with renal cell carcinoma: a single-center study. December 31, 2019

Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum. December 31, 2019

The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma. December 31, 2019

Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients. December 30, 2019

MicroRNA-429 inhibits cancer cell proliferation and migration by targeting AKT1 in renal cell carcinoma. December 30, 2019

The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma. December 30, 2019

GPX1, a biomarker for the diagnosis and prognosis of kidney cancer, promotes the progression of kidney cancer. December 27, 2019

A cluster of long non-coding RNAs exhibit diagnostic and prognostic values in renal cell carcinoma. December 27, 2019

The Metastasis of Renal Cell Carcinoma to the Urethra and Local Tumor Recurrence. December 27, 2019

The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment. December 26, 2019

The mRNA Expression Signature and Prognostic Analysis of Multiple Fatty Acid Metabolic Enzymes in Clear Cell Renal Cell Carcinoma. December 26, 2019

C-Reactive Protein Levels and Survival Following Cytoreductive Nephrectomy in 118 Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Study. December 26, 2019

Soluble immune checkpoint-related proteins as predictors of tumor recurrence, survival, and T cell phenotypes in clear cell renal cell carcinoma patients. December 25, 2019

Page 156 of 457